A Case of Guillain-Barré Syndrome and Stevens-Johnson Syndrome/Toxic Epidermal Necrosis Overlap After Pembrolizumab Treatment

A 76-year-old man was admitted to our hospital with Guillain-Barré syndrome (GBS), presenting with facial palsy, dysarthria, and dysphagia as Grade 3 immune-related adverse events (irAEs) due to pembrolizumab administration for Stage IV lung adenocarcinoma. Although prednisolone (1 mg/kg) was starte...

Full description

Bibliographic Details
Main Authors: Tomoyo Oguri MD, PhD, Shinji Sasada MD, PhD, Satoko Shimizu MD, Risa Shigematsu MD, Yumi Tsuchiya MD, Kota Ishioka MD, Saeko Takahashi MD, PhD, Koichi Oki MD, PhD, Yoshifumi Kimura MD, PhD, Reishi Seki MD, Shigemichi Hirose MD, PhD, Morio Nakamura MD, PhD
Format: Article
Language:English
Published: SAGE Publishing 2021-08-01
Series:Journal of Investigative Medicine High Impact Case Reports
Online Access:https://doi.org/10.1177/23247096211037462